Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.48 USD | +0.47% | -5.15% | +0.47% |
12:33pm | Wedbush Adjusts Voyager Therapeutics' PT to $8 From $10, Keeps Neutral Rating | MT |
05-13 | Transcript : Voyager Therapeutics, Inc., Q1 2024 Earnings Call, May 13, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.47% | 461M | |
+26.37% | 48.16B | |
-1.01% | 41.73B | |
+45.09% | 41.03B | |
-5.31% | 28.77B | |
+9.34% | 25.59B | |
-21.69% | 18.96B | |
+6.23% | 12.92B | |
+26.99% | 12.03B | |
-3.38% | 11.77B |
- Stock Market
- Equities
- VYGR Stock
- News Voyager Therapeutics, Inc.
- Wedbush Raises Voyager Therapeutics' Price Target to $10 From $4, Keeps Neutral Rating